Institutional investors purchased a net $7.6 million shares of PDLI during the quarter ended March 2016 and now own 78.34% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 2.4 Million shares of PDL BioPharma Inc
GRANTHAM, MAYO, VAN OTTERLOO & C... Bought 2.3 Million shares of PDL BioPharma Inc
JACOBS LEVY EQUITY MANAGEMENT, I... Bought 1.3 Million shares of PDL BioPharma Inc